ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts

February 14, 1986

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

In Brief: Three Comprehensive Centers Have Problems But Aren’t On “Probation”; Amos On Budget

June 9, 1978

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986